Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Yoshida

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Nephrology|May 31, 2021
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilitiesYuka Sugawara, Masao Iwagami, Yoko Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab]Chisa Fukasawa, Saori Ooishi, Takuma Kumagai, et al.
Journal of Diabetes|March 26, 2014
Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rateIsao Kawasaki, Yoshikazu Hiura, Anna Tamai, et al.
Renal Replacement Therapy|June 7, 2021
Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire surveyYuka Sugawara, Masao Iwagami, Kan Kikuchi, et al.
Fetal Diagnosis and Therapy|May 20, 2024
Valley Index as a Predictor of Prenatal Diagnosis of Total Anomalous Pulmonary Venous ConnectionWakako Maruyama, Yuki Kawasaki, Yosuke Murakami, et al.
Psychiatry Research|September 4, 2017
Predictors of short-term repetition of self-harm among patients admitted to an emergency room following self-harm: A retrospective one-year cohort studyYoko Yoshida Kawahara, Satoshi Hashimoto, Masahiro Harada, et al.
Clinical and Experimental Nephrology|March 8, 2018
Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndromeMadoka Fujisawa, Hideki Kato, Yoko Yoshida, et al.
Clinical and Experimental Nephrology|April 25, 2019
Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndromeMadoka Fujisawa, Hideki Kato, Yoko Yoshida, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 27, 2020
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 DiabetesMitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-Aki Matsuoka, et al.
Biochemical and Biophysical Research Communications|August 10, 2005
Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet countsMiho Ichiba, Takashi Shimomura, Rie Murai, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Nephrology|May 31, 2021
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilitiesYuka Sugawara, Masao Iwagami, Yoko Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab]Chisa Fukasawa, Saori Ooishi, Takuma Kumagai, et al.
Journal of Diabetes|March 26, 2014
Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rateIsao Kawasaki, Yoshikazu Hiura, Anna Tamai, et al.
Renal Replacement Therapy|June 7, 2021
Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire surveyYuka Sugawara, Masao Iwagami, Kan Kikuchi, et al.
Fetal Diagnosis and Therapy|May 20, 2024
Valley Index as a Predictor of Prenatal Diagnosis of Total Anomalous Pulmonary Venous ConnectionWakako Maruyama, Yuki Kawasaki, Yosuke Murakami, et al.
Psychiatry Research|September 4, 2017
Predictors of short-term repetition of self-harm among patients admitted to an emergency room following self-harm: A retrospective one-year cohort studyYoko Yoshida Kawahara, Satoshi Hashimoto, Masahiro Harada, et al.
Clinical and Experimental Nephrology|March 8, 2018
Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndromeMadoka Fujisawa, Hideki Kato, Yoko Yoshida, et al.
Clinical and Experimental Nephrology|April 25, 2019
Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndromeMadoka Fujisawa, Hideki Kato, Yoko Yoshida, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 27, 2020
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 DiabetesMitsuyoshi Takahara, Toshihiko Shiraiwa, Taka-Aki Matsuoka, et al.
Biochemical and Biophysical Research Communications|August 10, 2005
Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet countsMiho Ichiba, Takashi Shimomura, Rie Murai, et al.
Pageof 18